Browsing by Author "Lise Jamieson"
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
Item A costeffectiveness analysis of South Africas COVID19 vaccination programmeIjeoma Edoka; S Silal; Lise Jamieson; Gesine Meyer-RathItem Costeffectiveness of Remdesivir and Dexamethasone for COVID19 Treatment in South AfricaYoungji Jo; Lise Jamieson; Ijeoma Edoka; Lawrence Long; S Silal; J Pulliam; H Moultrie; Ian Sanne; Gesine Meyer-Rath; Brooke NicholsItem Differential inhospital mortality and intensive care treatment over time Informing hospital pathways for modelling COVID19 in South AfricaLise Jamieson; Cari Van Schalkwyk; Brooke E Nicholas; Gesine Meyer-Rath; Sheetal Silal; Juliet Pulliam; L Blumberg; Cheryl Cohen; Harry Moultrie; Waasila JassatItem The long wait for longacting HIV prevention and treatment formulationsWillem Venter; M Gandhi; Simiso Sokhela; K Sikwese; H Bygrave; L Da Gama; E et al; Lise Jamieson; Gesine Meyer-Rath; Karlien MöllerItem A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study(BIOMED CENTRAL LTD) H Moola; A Phillips; B ten Brink; E Mudimu; Gesine Meyer-Rath; Lise Jamieson; E et alItem Steep Declines in Pediatric AIDS Mortality in South Africa despite Poor Progress Toward Pediatric Diagnosis and Treatment TargetsL Johnson; M Patrick; C Stephen; G Patten; Mhairi Maskew; Lise Jamieson; E et al.Item Tenyear health impact economic impact and return on investment of the South African molecular diagnostics programme for HIV tuberculosis and SARSCoV2Brooke Nichols; A de Nooy; Naseem Cassim; Lucia Hans; Manuel Da Silva; K Chetty; K. H Grantz; A. X Han; A. N Phillips; Lise Jamieson; Lesley Scott; Wendy StevensItem The impact of selfselection based on HIV risk on the costeffectiveness of preexposure prophylaxis in South AfricaLise Jamieson; Gabriela B Gomez; Kevin Rebe; Ben Brown; Hasina Suberdah; E et al; Gesine Meyer-Rath